Elite Pharmaceuticals ( (ELTP) ) has issued an update. Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting ...
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor ...
Hosted on MSN1mon
Elite Pharmaceuticals' Stock Up Despite Q2 Earnings DeclineShares of Elite Pharmaceuticals, Inc. ELTP have gained 12.2% since the company released its earnings for the quarter ended Sept. 30, 2024, outperforming the S&P 500 index's decline of 2% during ...
Short interest in Elite Pharmaceuticals Inc (OTC:ELTP) decreased during the last reporting period, falling from 2.72M to 2.01M. This put 0.24% of the company's publicly available shares short.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
View Elite Pharmaceuticals, Inc. (ELTP) current and estimated P/E ratio data provided by Seeking Alpha.
ELITE PHARMACEUTICALS INC /NV/ - 8-K, Current Report 26.12.24 Elite Pharmaceuticals bringt generisches ADHS-Medikament auf den Markt 26.12.24 Elite Pharmaceuticals launches generic ADHD medication ...
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback